Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 108,665 | 77,141 | 0 | 0 |
| Gross Profit | 108,665 | 77,141 | N/A | N/A |
| Operating Expenses | 112,979 | 94,566 | 0 | 0 |
| Operating Income | -4,314 | -17,425 | N/A | N/A |
| Other Income | 3,821 | 2,206 | 0 | 0 |
| Pre-tax Income | -493 | -15,219 | 0 | 0 |
| Income Tax | 0 | -1,060 | N/A | N/A |
| Net Income Continuous | -493 | -14,159 | N/A | N/A |
| Net Income | $-493 | $-14,159 | $N/A | $N/A |
| EPS Basic Total Ops | -0.08 | -2.37 | N/A | N/A |
| EPS Basic Continuous Ops | -0.08 | -2.38 | N/A | N/A |
| EPS Diluted Total Ops | -0.08 | -2.37 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.08 | -2.38 | N/A | N/A |
| EBITDA(a) | $2,033 | $-10,743 | $N/A | $N/A |